Format
Sort by
Items per page

Send to

Choose Destination

Best matches for fetal growth AND mothers AND pregnancy AND selective serotonin re-uptake inhibitor:

Search results

Items: 1 to 20 of 25

2.

Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors.

Videman M, Tokariev A, Saikkonen H, Stjerna S, Heiskala H, Mantere O, Vanhatalo S.

Cereb Cortex. 2017 Jun 1;27(6):3208-3216. doi: 10.1093/cercor/bhw153.

PMID:
27269962
3.

Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study.

Jha SC, Meltzer-Brody S, Steiner RJ, Cornea E, Woolson S, Ahn M, Verde AR, Hamer RM, Zhu H, Styner M, Gilmore JH, Knickmeyer RC.

Psychiatry Res Neuroimaging. 2016 Jul 30;253:43-53. doi: 10.1016/j.pscychresns.2016.05.004. Epub 2016 May 24.

4.

Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.

Velasquez JC, Goeden N, Herod SM, Bonnin A.

ACS Chem Neurosci. 2016 Mar 16;7(3):327-38. doi: 10.1021/acschemneuro.5b00287. Epub 2016 Jan 30.

5.

Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.

Grzeskowiak LE, Gilbert AL, Sørensen TI, Olsen J, Sørensen HT, Pedersen LH, Morrison JL.

Ann Epidemiol. 2013 Nov;23(11):681-7. doi: 10.1016/j.annepidem.2013.08.005. Epub 2013 Oct 7.

PMID:
24113367
6.

The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.

Weikum WM, Mayes LC, Grunau RE, Brain U, Oberlander TF.

Infant Behav Dev. 2013 Dec;36(4):485-93. doi: 10.1016/j.infbeh.2013.04.001. Epub 2013 May 30.

PMID:
23728194
7.

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.

Arch Gen Psychiatry. 2012 Jul;69(7):706-14. doi: 10.1001/archgenpsychiatry.2011.2333.

PMID:
22393202
8.

Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.

Pawluski JL, Brain UM, Underhill CM, Hammond GL, Oberlander TF.

Psychoneuroendocrinology. 2012 Jul;37(7):1019-28. doi: 10.1016/j.psyneuen.2011.11.011. Epub 2011 Dec 15.

PMID:
22177580
9.

Perinatal selective serotonin reuptake inhibitor exposure: impact on brain development and neural plasticity.

Pawluski JL.

Neuroendocrinology. 2012;95(1):39-46. doi: 10.1159/000329293. Epub 2011 Aug 31. Review.

PMID:
21893935
10.

Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density.

Dubnov-Raz G, Hemilä H, Vurembrand Y, Kuint J, Maayan-Metzger A.

Early Hum Dev. 2012 Mar;88(3):191-4. doi: 10.1016/j.earlhumdev.2011.08.005. Epub 2011 Sep 3.

PMID:
21890289
11.

The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.

Wachman EM, Newby PK, Vreeland J, Byun J, Bonzagni A, Bauchner H, Philipp BL.

J Addict Med. 2011 Dec;5(4):293-9. doi: 10.1097/ADM.0b013e3182266a3a.

PMID:
21857233
12.

Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.

Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF.

Pediatrics. 2009 Oct;124(4):e662-70. doi: 10.1542/peds.2009-0442. Epub 2009 Sep 28.

PMID:
19786426
13.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

Gentile S, Bellantuono C.

J Clin Psychiatry. 2009 Mar;70(3):414-22. Epub 2009 Feb 24. Review.

PMID:
19254517
14.

[Use of SSRIs during pregnancy and possible consequences for the development of the child].

van der Veere CN, Bos AF.

Ned Tijdschr Geneeskd. 2007 Dec 29;151(52):2873-4. Dutch.

PMID:
18257430
15.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
16.

Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.

Sivojelezova A, Shuhaiber S, Sarkissian L, Einarson A, Koren G.

Am J Obstet Gynecol. 2005 Dec;193(6):2004-9.

PMID:
16325604
17.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
18.

SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome.

Gentile S.

CNS Drugs. 2005;19(7):623-33. Review.

PMID:
15984897
20.

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.

Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE.

J Pediatr. 2003 Apr;142(4):402-8.

PMID:
12712058

Supplemental Content

Loading ...
Support Center